|
|
|
|
Overview of Cholesterol Transport
|
|
|
|
Cholesterol transporter
|
|
|
|
Postprandial lipidemia
|
|
|
|
Copenhagen City Heart Study
|
|
|
|
Triglyceride levels and levels of remnant lipoprotein cholesterol
|
|
|
|
Levels of Remnant Lipoprotein Cholesterol
|
|
|
|
Non-fasting triglycerides and risk for MI, IHD and death in Women
|
|
|
|
Non-fasting triglycerides and risk for MI, IHD and death in Men
|
|
|
|
Women’s Health Study (WHS)
|
|
|
|
Association of triglyceride levels with incident CVD
|
|
|
|
Womens Health Study (WHS)
|
|
|
|
Triglyceride concentrations
|
|
|
|
Drop in HDL-c after an oral fatload
|
|
|
|
Increase in Cholesterol Ester Transfer (CET) after an oral fatload
|
|
|
|
Oral Triglyceride Tolerance Test!??
|
|
|
|
Effect of statin versus fibrate
|
|
|
|
Ezetimibe improves postprandial hyperlipemia
|
|
|
|
Ezetimibe improves postprandial hyperlipemia
|
|
|
|
Low-dose statin and ezetimibe compared to high-dose simvastatin on
|
|
|
|
Low-dose statin and ezetimibe compared to high-dose simvastatin
|
|
|
|
Low-dose statin and ezetimibe compared to high-dose simvastatin on
|
|
|
|
Low-dose statin and ezetimibe compared to high-dose simvastatin on
|
|
|
|
Conclusions
|
|
|
|
The PANACEA Study
|
|
|
|
The PANACEA Study
|
|
|
|
The PANACEA Study
|
|
|
|
PANACEA trial design
|
|
|
|
Conclusions
|
|
Download Presentation (PPTX 2.9MB)
Share this page with your colleagues and friends: